Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Clarke

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Advances in Cancer Research|August 1, 2018
Neutral Sphingomyelinases in Cancer: Friend or Foe?Christopher J Clarke
Pharmacology & Therapeutics|September 28, 2021
Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapyDaniel Canals, Christopher J Clarke
Biochimica Et Biophysica Acta|August 30, 2006
Neutral sphingomyelinases and nSMase2: bridging the gapsChristopher J Clarke, Yusuf A Hannun
Molecular Pharmacology|February 15, 2024
Special Section on Therapeutic Implications for Sphingolipids in Health and Disease-EditorialChristopher J Clarke, Ashley J Snider
Nature Chemical Biology|April 25, 2024
Pyro(phospho)maniaClaire E Eyers, Christopher J Clarke
Toxicologic Pathology|March 14, 2008
Metabolic profiling as a tool for understanding mechanisms of toxicityChristopher J Clarke, John N Haselden
Molecular Pharmacology|February 15, 2024
Perspective: Therapeutic Implications for Sphingolipids in Health and DiseaseChristopher J Clarke, Ashley J Snider
Current Opinion in Pediatrics|July 21, 2009
The risk of long QT syndrome in the pediatric populationChristopher J Clarke, George M McDaniel
Biochemical Society Transactions|October 22, 2025
Are you having a LaPh? Diverse roles of Labile Phosphorylation in mammalian cellsChristopher J Clarke, Claire E Eyers
American Journal of Physiology. Heart and Circulatory Physiology|January 9, 2007
Norepinephrine and endothelin activate diacylglycerol kinases in caveolae/rafts of rat mesenteric arteries: agonist-specific role of PI3-kinaseChristopher J Clarke, Vasken Ohanian, Jacqueline Ohanian
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Advances in Cancer Research|August 1, 2018
Neutral Sphingomyelinases in Cancer: Friend or Foe?Christopher J Clarke
Pharmacology & Therapeutics|September 28, 2021
Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapyDaniel Canals, Christopher J Clarke
Biochimica Et Biophysica Acta|August 30, 2006
Neutral sphingomyelinases and nSMase2: bridging the gapsChristopher J Clarke, Yusuf A Hannun
Molecular Pharmacology|February 15, 2024
Special Section on Therapeutic Implications for Sphingolipids in Health and Disease-EditorialChristopher J Clarke, Ashley J Snider
Nature Chemical Biology|April 25, 2024
Pyro(phospho)maniaClaire E Eyers, Christopher J Clarke
Toxicologic Pathology|March 14, 2008
Metabolic profiling as a tool for understanding mechanisms of toxicityChristopher J Clarke, John N Haselden
Molecular Pharmacology|February 15, 2024
Perspective: Therapeutic Implications for Sphingolipids in Health and DiseaseChristopher J Clarke, Ashley J Snider
Current Opinion in Pediatrics|July 21, 2009
The risk of long QT syndrome in the pediatric populationChristopher J Clarke, George M McDaniel
Biochemical Society Transactions|October 22, 2025
Are you having a LaPh? Diverse roles of Labile Phosphorylation in mammalian cellsChristopher J Clarke, Claire E Eyers
American Journal of Physiology. Heart and Circulatory Physiology|January 9, 2007
Norepinephrine and endothelin activate diacylglycerol kinases in caveolae/rafts of rat mesenteric arteries: agonist-specific role of PI3-kinaseChristopher J Clarke, Vasken Ohanian, Jacqueline Ohanian
Pageof 9